We'll look at where the research stands, what these treatments could offer, and the promise they hold for a future free from the constraints of ED
Such self-diagnostic tools could reduce healthcare system burden and facilitate earlier detection with greater convenience
Learnings from this initial 3-year phase will inform the rollout to a wider group of eligible patients over a maximum period of 12 years
GLP-1 medications run between $617 and $766 per month at list price and when large employers began covering them at scale, the impact on pharmacy benefit spending was immediate and significant. The numbers tell the story clearly
It had been a few years since Mojsov left Mass General, and while she was there, she had twice spoken with its intellectual property office about a patent for GLP-1
The researchers concluded that short-term DSIP treatment is unlikely to be a major therapy for chronic insomnia, though it may have minor benefits